Yervoy for metastatic melanomaDrug is for patients who have failed or do not tolerate other systemic therapy for advanced disease. Fatigued cancer patients lose muscle massResistance training might improve quality of life, researcher speculates Zelboraf for unresectable or metastatic melanoma New oral monotherapy for the treatment of BRAF V600 mutation-positive unresectable or metastatic melanoma. New caps and collars ease radiation protection burden Lighter-weight garments include novel cap to protect the head Stent relieves compression of pulmonary artery caused by cancer Unusual use of stent allowed lung cancer patient to breathe easier Calcium linked to lower endometrial cancer risk Caprelsa for advanced thyroid cancer First drug to be approved for the treatment of rare thyroid cancer. Urine biomarkers may predict aggressive prostate cancer Prostate-specific antigen velocity risk count superior to single PSA test Metformin stymies mutations and DNA damage in cells which lead to cancer First Previous 51 52 53 54 55 Next Last
